Significance of serum connective tissue growth factor in patients with hepatocellular carcinoma and relationship with angiogenesis

World Journal of Surgery

Volumn 34, Issue 10, 2010, Pages 2411-2417

  Wang, Gui Bo ^a   Zhou, Xin Yu ^a   Yuan, Tao ^b   Xie, Jun ^b   Guo, Li Ping ^b   Gao, Ning ^a   Wang, Xiao Qin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR;

ARTICLE; BIOSYNTHESIS; BLOOD; DISEASE COURSE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PROGNOSIS; SURVIVAL;

CARCINOMA, HEPATOCELLULAR; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 77957159672     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0648-4     Document Type: Article

References (29)

1. WY Lau EC Lai 2008 Hepatocellular carcinoma: current management and recent advances Hepatobiliary Pancreat Dis Int 7 237 257 18522878
2. X Lu H Zhao H Yang, et al. 2009 A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy J Surg Oncol 100 488 493 10.1002/jso.21354 19653238
3. CD Mann CP Neal G Garcea, et al. 2007 Prognostic molecular markers in hepatocellular carcinoma: a systematic review Eur J Cancer 43 979 992 1:CAS:528:DC%2BD2sXjslGnurY%3D 10.1016/j.ejca.2007.01.004 17291746
4. KP Holbourn B Perbal K Ravi Acharya 2009 Proteins on the catwalk: modelling the structural domains of the CCN family of proteins J Cell Commun Signal 3 25 41 10.1007/s12079-009-0048-4 19424823
5. T Aikawa J Gunn SM Spong, et al. 2006 Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer Mol Cancer Ther 5 1108 1116 1:CAS:528:DC%2BD28XltVWntLk%3D 10.1158/1535-7163.MCT-05-0516 16731742
6. N Dornhofer S Spong K Bennewith 2006 Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis Cancer Res 66 5816 5827 10.1158/0008-5472.CAN-06-0081 16740721
7. T Shimo S Kubota T Goda, et al. 2008 Clinical significance and pathogenic function of connective tissue growth factor (CTGF/CCN2) in osteolytic mandibular squamous cell carcinoma Anticancer Res 28 2343 2348 18751416
8. MY Wang PS Chen E Prakash, et al. 2009 Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1 Cancer Res 69 3482 3491 1:CAS:528:DC%2BD1MXksV2htrs%3D 10.1158/0008-5472.CAN-08-2524 19351859
9. CC Chang JY Shih YM Jeng, et al. 2004 Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis J Natl Cancer Inst 96 364 375 1:CAS:528:DC%2BD2cXhvFSqt7s%3D 10.1093/jnci/djh059 14996858
10. T Shimo S Kubota N Yoshioka, et al. 2006 Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer J Bone Miner Res 21 1045 1059 1:CAS:528:DC%2BD28XntlWqur0%3D 10.1359/jbmr.060416 16813525
11. W Chien D Yin D Gui A Mori, et al. 2006 Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non-small cell lung cancer cells Mol Cancer Res 4 591 598 1:CAS:528:DC%2BD28XotV2rt7c%3D 10.1158/1541-7786.MCR-06-0029 16877704
12. BR Lin CC Chang TF Che, et al. 2005 Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer Gastroenterology 128 9 23 1:CAS:528:DC%2BD2MXhtFahtrY%3D 10.1053/j.gastro.2004.10.007 15633118
13. LH Sobin ID Fleming 1997 TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer Cancer 80 1803 1804 1:STN:280:DyaK1c%2FhtF2itA%3D%3D 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9 9351551
14. R Pang RT Poon 2006 Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma Cancer Lett 242 151 167 1:CAS:528:DC%2BD28XhtVGit7rM 10.1016/j.canlet.2006.01.008 16564617
15. CY Chu CC Chang E Prakash ML Kuo 2008 Connective tissue growth factor (CTGF) and cancer progression J Biomed Sci 15 675 685 1:CAS:528: DC%2BD1MXjs1KhsQ%3D%3D 10.1007/s11373-008-9264-9 18622762
16. MR Chintalapudi M Markiewicz N Kose, et al. 2008 Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells Carcinogenesis 29 696 703 1:CAS:528:DC%2BD1cXktlOgsLo%3D 10.1093/carcin/bgn019 18212329
17. S Hirasaki N Koide K Ujike, et al. 2001 Expression of Nov, CYR61 and CTGF genes in human hepatocellular carcinoma Hepatol Res 19 294 305 1:CAS:528:DC%2BD38Xht1yhtLw%3D 10.1016/S1386-6346(00)00101-7 11251312
18. ZJ Zeng LY Yang X Ding, et al. 2004 Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance World J Gastroenterol 10 3414 3418 1:CAS:528:DC%2BD2cXhtFCht7jI 15526358
19. S Ai XW Cheng A Inoue, et al. 2007 Angiogenic activity of bFGF and VEGF suppressed by proteolytic cleavage by neutrophil elastase Biochem Biophys Res Commun 364 395 401 1:CAS:528:DC%2BD2sXht1aktL%2FI 10.1016/j.bbrc.2007.10.027 17950695
20. A Arkudas J Tjiawi O Bleiziffer, et al. 2007 Fibrin gel-immobilized VEGF and bFGF efficiently stimulate angiogenesis in the AV loop model Mol Med 13 480 487 1:CAS:528:DC%2BD2sXhtlShsL3N 10.2119/2007-00057.Arkudas 17762899
21. Y Chao CP Li GY Chau, et al. 2003 Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery Ann Surg Oncol 10 355 362 10.1245/ASO.2003.10.002 12734082
22. EA Kim ES Gershtein IV Vysotskaya, et al. 2008 Expression of VEGF and VEGFR2 in tumors during neoadjuvant therapy of patients with breast cancer Bull Exp Biol Med 145 245 248 1:CAS:528:DC%2BD1cXhtVWnsL3E 10.1007/s10517-008-0061-2 19023980
23. I Inoki T Shiomi G Hashimoto, et al. 2002 Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis FASEB J 16 219 221 1:CAS:528:DC%2BD38XhsVeqt7c%3D 11744618
24. G Hashimoto I Inoki Y Fujii, et al. 2002 Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor J Biol Chem 277 36288 36295 1:CAS:528: DC%2BD38XnsVCjtrY%3D 10.1074/jbc.M201674200 12114504
25. O Sala-Torra HM Gundacker DL Stirewalt, et al. 2007 Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia Blood 109 3080 3083 1:CAS:528:DC%2BD2sXjvVyntrY%3D 17170128
26. D Zhang NY Wang CB Yang, et al. 2009 The clinical value of serum connective tissue growth factor in the assessment of liver fibrosis Dig Dis Sci 55 767 774 10.1007/s10620-009-0781-9 19294506
27. Q Ding X He W Xia, et al. 2007 Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer Cancer Res 67 4564 4571 1:CAS:528: DC%2BD2sXltl2hu78%3D 10.1158/0008-5472.CAN-06-1788 17495324
28. LY Liu YC Han SH Wu, et al. 2008 Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer World J Gastroenterol 14 2110 2114 10.3748/wjg.14.2110 18395916
29. D Ribatti E Crivellato S Molica 2009 Mast cells and angiogenesis in haematological malignancies Leuk Res 33 876 879 1:CAS:528:DC%2BD1MXlsVGqurs%3D 10.1016/j.leukres.2009.02.028 19324412